Navigation Links
Longs Reports Preliminary February Retail Drug Store Sales
Date:3/6/2008

WALNUT CREEK, Calif., March 6 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation (NYSE: LDG) today reported preliminary total retail drug store sales of $379 million for the four-week period ended February 28, 2008, an increase of 3.2 percent from $368 million in the comparable period a year ago.

(Dollars in millions) 4 weeks ended February 28, 2008

Total retail drug store sales $379

Increase from comparable prior year

period 3.2%

Same-store sales increase:

Pharmacy 2.1%

Front-end 0.3%

Total 1.2%

About the Company

Headquartered in Walnut Creek, California, Longs Drug Stores Corporation (NYSE: LDG) is one of the most recognized retail drug store chains on the West Coast and in Hawaii. The Company operates 510 retail pharmacies and offers a wide assortment of merchandise focusing on health, wellness, beauty and convenience. Longs also provides pharmacy benefit management services and Medicare beneficiary prescription drug plans through its wholly-owned subsidiary, RxAmerica, LLC. Additional information about Longs and its services is available at http://www.longs.com and more information about RxAmerica is available at http://www.rxamerica.com.

Contact: Phyllis Proffer

925-979-3979


'/>"/>
SOURCE Longs Drug Stores Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
2. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
3. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
4. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics
6. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
7. Longs Drugs Announces Immunization Program for the 2007/2008 Flu Season
8. CRH Medical reports preliminary year end results
9. Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results
10. Carriage Services Reports 2007 Full Year Results
11. General Nutrition Centers, Inc. Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... ... century approach to infusing high speed technology into the fabric of an entire ... the advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading ...
(Date:1/17/2017)... ... 17, 2017 , ... Surgeons from New York’s fastest growing ... on the latest breakthroughs in the prevention, diagnosis and treatment of the most ... eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD and Managing ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading ... a Principal in its IT Advisory Services practice . Rossi is the third ... market demand for strategic IT guidance grows, and the practice continues to expand.     , ...
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 ... ... Inc. Magazine’s fastest-growing private companies and ranked among the top US security companies ... Board of Directors. This announcement brings a year-long independent board nomination process ...
(Date:1/16/2017)... , ... January 17, 2017 , ... Recently, patients and ... Southwest Michigan, joined other volunteers and organizations in support of the annual Binder Park ... and families dressed up in colorful costumes of all designs coming out to enjoy ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan 17, 2017 Research and ... Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), ... - Global Forecast to 2021" report to their offering. ... The global active ... 2021 from USD 157.95 Billion in 2016, growing at a CAGR ...
(Date:1/17/2017)... 17, 2017 Immune Pharmaceuticals (NASDAQ: ... today that it will hold a Satellite Symposium on February ... (ISAL) XVI in Munich, Germany . ... Efficacy of Immunotherapy for the maintenance of remission in ... 20 th , 2017 from 12:45 – 13:45 CET ...
(Date:1/17/2017)... PARSIPPANY, N.J. , Jan. 17, 2017 Interpace ... that provides clinically useful molecular diagnostic tests and pathology ... it has received a letter dated January 13, 2017 ... it has regained compliance with the requirement of the ... price of $1.00 per share. The letter ...
Breaking Medicine Technology: